The erythromelalgia treatment market — therapies for a rare neurovascular pain disorder characterized by episodic burning pain, redness, and elevated skin temperature in the extremities, frequently linked to gain-of-function mutations in sodium channel genes — remains a small but steadily growing niche within rare disease pharmaceuticals, with the Erythromelalgia Treatment Market...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek